RecruitingBreast CarcinomaColorectal CarcinomaLung Non-Small Cell Carcinoma

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Eligible age

18+ yrs

Accepts

All genders

Locations

42 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

Sponsor: Wake Forest University Health Sciences

You may qualify if…

✓ Adults aged 18 years or older with one of the following newly diagnosed cancers: breast cancer, colorectal cancer, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer (e.g. adenocarcinoma, squamous cell carcinoma, large cell carcinoma, adenosquamous cell carcinoma, and not otherwise specified).
✓ Planned treatment with systemic chemotherapy (single or multi-agent, includes targeted therapy) and/or immune checkpoint inhibitor therapy (targeting PD-1, PD-L1 or CTLA-4). If unable to engage participant before treatment starts, enrollment is allowed up to the start of Cycle 2 treatment.
✓ Participants must be able to comprehend English or Spanish (for survey completion).
✓ Participants must have a working email address and be must be willing to complete surveys online. This can be completed at home, in the clinic or other location.
✓ Completion of the confidential Self-Reported Screening Survey and receipt of a screening result - eligible for enrollment.
✓ Participant must reside in the United States, officially determined per patient report on Self-reported Screening Survey
✓ In the treating provider's opinion, the participant should have a life expectancy of \>=6 months. Participants in hospice are not eligible.
✓ Optional Sub-study (available at select sites only):

You may not qualify if…

✕ Currently enrolled in an interventional supportive treatment trial to manage cancer symptoms.
✕ Participants with known pregnancy.
✕ Participant received systemic therapy treatment for prior cancer(s) including chemotherapy, immunotherapy, targeted therapy, and hormonal therapy.
✕ Participants enrolled in hospice.
✕ Optional Substudy (available at select sites only):
✕ Participants with chronic or ongoing steroid or immunomodulatory agents (i.e., prednisone, dexamethasone, etanercept, infliximab, etc.). The use of glucocorticoids as pre-medications for chemotherapy treatment is allowed.
✕ Participants with a history of HIV, hepatitis B or hepatitis C.